CTIC - CTI BioPharma Corp.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue26,29025,14657,40516,116
Cost of Revenue8793641,3771,940
Gross Profit25,41124,78256,02814,176
Operating Expenses
Research Development36,46732,86662,96174,627
Selling General and Administrative21,18331,43547,30655,962
Non Recurring----
Others----
Total Operating Expenses58,52964,665111,644132,529
Operating Income or Loss-32,239-39,519-54,239-116,413
Income from Continuing Operations
Total Other Income/Expenses Net2,887-1,3121,286-4,350
Earnings Before Interest and Taxes-32,239-39,519-54,239-116,413
Interest Expense-1,734-2,035-2,828-2,494
Income Before Tax-29,352-40,831-52,953-120,763
Income Tax Expense----
Minority Interest-5,755-5,723-5,562-4,618
Net Income From Continuing Ops-29,352-40,831-52,953-120,763
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-29,320-40,670-52,009-119,422
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-29,400-45,020-52,009-122,622